Alloreactive natural killer cell therapy for multiple myeloma
Abstract. Disease relapse is an important problem after allogeneic stem cell transplantations in multiple myeloma (MM). To test the.
BMT CTN Protocol 0201, URD PB vs BM - ClinicalTrials.govThe PhD thesis studies the mechanisms of regulation of the activation of Natural Killer cells, focusing on their anti-tumor activity. Le Fc?RIIIA/CD16A des cellules Natural Killer (NK) humainesMembrane expression of the killer immunoglobulin-like receptor (KIR) KIR2DL4 on peripheral blood NK (pNK) cells is controlled by the 9A/10A ... Caractérisation de l'hétérogénéité tumorale et du compartiment ...sequence homology suggests that KIR genes are quences are apparently alleles at a single locus (Gardi- likely to be regulated by a stochastic mechanism, possi-.
Autres Cours:
